You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +44 (0)20 7769 6707 or email: apus@templetonapus.com |
|
Most viewed
- 1. Links 15/7/2020: New PinePhone, GCC 10.2 Release Candidate
- 2. PARP Inhibitors in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Meta-Analysis of Randomized Clinical Trials
- 3. VCU Partners with Kallaco Health & Technology for Student and Employee COVID-19 Testing
- 4. TriSalus Life Sciences Acquires Dynavax's SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales
- 5. COVID-19 May Have Been a Barrier to Radiotherapy for Established Cancer Patients
- 6. COVID-19 Update: Over 18 Million Confirmed Cases Worldwide; Update on US Stimulus Negotiations; and More
- 7. Calidi Biotherapeutics Announces FDA Approval for COVID-19 Treatment Manufactured by Partner: Personalized Stem Cells
- 8. PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC
- 9. 2x Teenage Colon Cancer Survivor Writes Memoir to Inspire Girls and their Parents
- 10. CURE's Top Stories: July 2020
Last updated at 10:37 GMT
Hot News Makers
Health/Pharma Companies
-
49681.87
-
29449.16
-
27091.56
-
19619.12
-
13826.94
-
13641.15
-
13515.82
-
13078.01
-
11995.73
-
10138.70
Last updated at 10:10 GMT
© Copyright 2020 Templeton Apus. All rights reserved.
Made with 
and
in the EU & the UK
and
in the EU & the UK